Form 4: Alector Principal Accounting Officer Sells Shares

Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc., sold 9,184 shares to cover tax obligations related to RSU vesting.

Summary

• Grace Wong-Sarad, Principal Accounting Officer of Alector, Inc., executed sales of 9,184 shares of common stock on June 2 and June 3, 2026.
• The sales were conducted to satisfy tax withholding obligations resulting from the vesting of restricted stock units (RSUs).
• The transactions were executed at weighted average prices of $1.9742 and $1.8828 per share.
• Following these transactions, the reporting person retains beneficial ownership of 95,461 shares of Alector common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a strategic shift.

Positives

• The sale was a routine administrative action to satisfy tax obligations rather than a discretionary divestment of holdings.

Negatives

• The sale reflects a reduction in the insider's direct equity stake in the company.

Risks

• The reporting person remains subject to market volatility regarding the remaining 95,461 shares held.

Future Outlook

No forward-looking guidance regarding company performance was provided in this filing.

Management Comments

• The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that insider sales to cover tax obligations upon RSU vesting are standard corporate practice and generally do not signal a change in management sentiment regarding the company's long-term prospects.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a standard industry practice for executives to manage equity sales in compliance with SEC regulations.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was pre-planned and tax-related.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Alector, ALEC, Insider Trading, Form 4, Biotech, Equity Compensation